Hematology NewsFDA: Safety signal emerged with higher dose of tofacitinib in RA studyFebruary 26, 2019ThrombosisGastroenterologyGastrointestinal Cancer
Hematology NewsFDA clears test to monitor residual disease in CMLFebruary 22, 2019CMLLeukemia, Myelodysplasia, Transplantation
Hematology NewsFDA grants priority review to polatuzumab vedotin for DLBCLFebruary 20, 2019B Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA approves turoctocog alfa pegol for hemophilia AFebruary 20, 2019Bleeding Disorders
Hematology NewsFDA approves daratumumab split-dosing regimen in MMFebruary 13, 2019Multiple MyelomaLymphoma & Plasma Cell Disorders
Hematology NewsFDA: 246 new reports on breast implant-associated lymphomaFebruary 7, 2019T Cell LymphomasLymphoma & Plasma Cell Disorders
Hematology NewsFDA grants BI-1206 orphan designation for MCLFebruary 1, 2019Mantle Cell LymphomaLymphoma & Plasma Cell Disorders
Hematology NewsIPH4102 on fast track for Sézary syndromeJanuary 30, 2019T Cell LymphomasLymphoma & Plasma Cell DisordersNonmelanoma Skin Cancer
Hematology NewsFDA approves ibrutinib plus obinutuzumab for CLL/SLLJanuary 28, 2019CLLLeukemia, Myelodysplasia, Transplantation
Hematology TimesEC approves blinatumomab for MRD-positive BCP-ALLJanuary 25, 2019Leukemia, Myelodysplasia, TransplantationALL
Hematology NewsUmbralisib gains FDA breakthrough designation for MZLJanuary 25, 2019Indolent LymphomaLymphoma & Plasma Cell Disorders
Oncology PracticeFDA approves third trastuzumab biosimilarJanuary 18, 2019Breast CancerGastroenterologyGastrointestinal Cancer
Hematology NewsZanubrutinib receives breakthrough designation for MCLJanuary 18, 2019Mantle Cell LymphomaAggressive LymphomasLymphoma & Plasma Cell Disorders
Oncology PracticeFDA approves cabozantinib for previously treated HCCJanuary 15, 2019GastroenterologyGI OncologyGastrointestinal Cancer
